MedPage Today1d
FDA OKs First Drug for Hyperphagia in Prader-Willi Syndrome
Diazoxide choline is the first drug indicated for hyperphagia in the rare genetic disorder. Prior to approval, people with ...
Soleno Shares Soar Premarket on FDA Approval of Vykat XR
Soleno on Wednesday said the FDA approved its Vykat XR extended-release tablets for the treatment of hyperphagia, a chronic and life-threatening feeling of intense, persistent hunger, in people ages 4 ...
Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome
First approved therapy to address hyperphagia in individuals with Prader-Willi syndromeManagement to host conference call and webcast today, ...
US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome
The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...
Soleno Therapeutics announces FDA approval of VYKATTM XR to treat hyperphagia
Soleno Therapeutics (SLNO) “announced that the FDA has approved VYKAT XR, diazoxide choline, extended-release tablets, previously referred to ...
Philippine News Agency7d
FDA expands list of VAT-exempt meds for non-communicable diseases
The Food and Drug Administration (FDA) has expanded the list of medicines for non-communicable diseases (NCDs) exempted from ...
AOL20d
Ozempic vs Metformin For Weight Loss: Weighing the Pros & Cons of Each
Most people start with a weekly Ozempic dosage of 0.25mg, then increase the dose to 0.5 mg after four weeks. Unlike Ozempic, metformin is an extended-release oral medication with a recommended ...
Medical News Today23d
Is hair loss a side effect of metformin?
In May 2020, the Food and Drug Administration (FDA) recommended that some makers of metformin extended release remove some of their tablets from the U.S. market. This is because an unacceptable ...